NASDAQ · Medical - Devices

Envoy Medical, Inc. (COCH) Stock

$0.66 +0.03% NASDAQ: COCH Healthcare

Valuation

MetricValue
Price$0.66
Market Cap$50.78M
P/E Ratio-0.97
P/B Ratio20.51
P/S Ratio242.77
EPS (TTM)$0.00
52-Week High$1.89
52-Week Low$0.36
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE239.44%
ROA-97.71%
ROCE-208.76%
Gross Margin0.00%
Operating Margin0.00%
Net Margin-98.76%
Debt/Equity0.25
Current Ratio0.50

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-7.0M$-9.0M$-18.0M$-19.0M$-22.0M
Net Profit$-9.0M$-16.0M$-30.0M$-21.0M$-24.0M
EPS$-1.05$-1.57$-2.54$-1.49$-1.23
Op Margin-2216.4%-3673.4%-5809.8%-8558.2%-9240.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$3.0M$3.0M$8.0M$12.0M$9.0M
Total Liabilities$48.0M$39.0M$10.0M$30.0M$20.0M
Cash$1.0M$0$4.0M$5.0M$4.0M
Borrowings$23.0M$35.0M$1.0M$20.0M$1.0M

Latest News

Envoy Medical Surpasses Three-Month Visit Milestone for All 56 Patients in Pivotal Clinical Trial TMX Newsfile · Jul 21, 2026 EXCLUSIVE: Envoy Medical Hits Key Clinical Trial Milestone for Fully Implanted Ear Implant Benzinga · Jul 21, 2026 Envoy Medical Reports Positive 12-Month Data Showing Continued Improvement in Speech Perception in Study of First-of-Its-Kind Fully Implanted Cochlear Implant TMX Newsfile · Jul 14, 2026 EXCLUSIVE: Envoy Medical Builds Momentum With Improved Cochlear Implant Trial Results Benzinga · Jul 14, 2026 AngioDynamics (ANGO) Reports Q4 Loss, Beats Revenue Estimates Zacks · Jul 14, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-7.0M$-9.0M$-17.0M$-18.0M$-18.0M
Investing Cash Flow$0$0$0$-2.0M$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$1.0M$0$4.0M$1.0M$-2.0M
Free Cash Flow$-7.0M$-9.0M$-17.0M$-19.0M$-18.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.01
EV / EBITDA-1.43
FCF Yield-43.20%
Quick Ratio1.61
Interest Coverage-50.15
Return 1Y-55.88%
Return 3Y-92.94%
Return 5Y-92.52%

Ownership

Insiders Held40.50%
Institutions Held22.90%
Institutions Float Held38.50%
Institutional HolderSharesReport Date
Nantahala Capital Management, LLC7,650,0002026-03-31
Bleichroeder LP6,250,0002026-03-31
Vanguard Capital Management LLC881,6722026-03-31
Dsg Capital Advisors, LLC 625,0002026-03-31
Geode Capital Management, LLC521,8242026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADGMAdagio Medical Holdings, Inc $0.13 +0.00% -0.09 $2.89M 0.00%
ADTX $0.01 -77.22% -0.01 $318 0.00%
ALURAllurion Technologies Inc. $4.72 -14.27% -0.08 $4.72M 0.00%
ATHAAthira Pharma, Inc. $6.75 -6.12% -0.28 $26.62M 0.00%
CODXCo-Diagnostics, Inc. $1.12 +2.75% -0.04 $7.00M 0.00%

About Envoy Medical, Inc.

Envoy Medical, Inc. is led by CEO Brent T. Lucas, employs 42 people, headquartered in US, publicly traded since 2021.

Envoy Medical, Inc. (COCH) stock trades at $0.66 with a market capitalization of $50.78M. The stock is valued at a price-to-earnings (P/E) ratio of -0.97, price-to-book of 20.51, price-to-sales of 242.77. Over the past 52 weeks the stock has ranged between $0.36 and $1.89, and currently trades 65.1% below its 52-week high.

On profitability, Envoy Medical, Inc. generates a return on equity (ROE) of 239.44% — well above the market average, a sign of a high-quality business, return on capital employed of -208.76%, an operating margin of 0.00%, a net profit margin of -98.76%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides